Fidia to acquire Sooft

The Italian group SOOFT, specialized in ophthalmic products, sold 80% of the company to Fidia Farmaceutici. Carlo Pizzoccaro, currently Fidia CEO and chairman, has reportedly announced the transaction, without providing its financial details. Sooft generated approximately €60m in revenue in 2016. Following the acquisition, Fidia can now add to its portfolio the brands Sooft, Bioos, Glaucoom, OftaH.T. and Neoox, which will allow the Abano-headquartered group to yield a revenue of €300m in 2017. Angelini and Mediolanum Farmaceutici were rumored as potential acquirers of Sooft some months ago. (Source Il Sole 24 Ore and Fidia)